Danna Perlman
Keine laufenden Positionen mehr
Profil
Danna Perlman formerly worked at Prize4Life, Inc., as Director from 2013 to 2018, Microbot Medical, Inc., as Director-Strategy Development from 2014 to 2020, and Lavie, Michlin & Co., as Associate Attorney.
Ms. Perlman received her undergraduate degree and graduate degree from the University of Haifa.
Ehemalige bekannte Positionen von Danna Perlman
Unternehmen | Position | Ende |
---|---|---|
MICROBOT MEDICAL INC. | Corporate Officer/Principal | 01.12.2020 |
Prize4Life, Inc.
Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Prize4Life, Inc. is a non-profit organization that aims to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease. Prize4Life uses powerful incentives to attract new people and drive innovation in ALS research. The American company believes that out-of-the-box thinking is necessary to find solutions to the biggest challenges in ALS research, and that critical discoveries may come from unlikely places. Prize4Life encourages and rewards creative approaches that will yield real results for ALS patients. The non-profit company was founded by Guy Yamen and Nate Boaz in 2007. | Direktor/Vorstandsmitglied | 01.01.2018 |
Lavie, Michlin & Co. | Corporate Officer/Principal | - |
Ausbildung von Danna Perlman
University of Haifa | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MICROBOT MEDICAL INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Prize4Life, Inc.
Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Prize4Life, Inc. is a non-profit organization that aims to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease. Prize4Life uses powerful incentives to attract new people and drive innovation in ALS research. The American company believes that out-of-the-box thinking is necessary to find solutions to the biggest challenges in ALS research, and that critical discoveries may come from unlikely places. Prize4Life encourages and rewards creative approaches that will yield real results for ALS patients. The non-profit company was founded by Guy Yamen and Nate Boaz in 2007. | Commercial Services |
Lavie, Michlin & Co. |